The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Traws Pharma, Inc. ( NASDAQ: TRAW) Virtual Investor Event March 31, 2025 10:00 AM ET Werner Cautreels – Chief Executive Officer Robert Redfield – Chief Medical Officer David Pauza – Chief Science ...

United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

Full Year 2024 Results Key Financial Results Net loss: US$56.2m (loss ...

BUFFALO, N.Y. (WIVB) — A dozen people were displaced by a fire on Monday morning at a large home with multiple residences on ...

The Lake Avenue bridge opened on July 10, 1973. A portion of the 1937 bridge it replaced remained beside the new bridge until ...

Knight Therapeutics Inc., a pharmaceutical company with a market capitalization of $435 million, reported record revenues of $365 million for the year 2024, marking a 6% increase from the previous ...

"The north of England has won 10 Champions League medals, London has two. But London has Wembley, Twickenham, Wimbledon and the Olympic Village," said the United co-owner. "The north of England ...

Aditxt, Inc. (NASDAQ:ADTX), a biotech company, is currently in default for failing to pay over $40,000 in rent and additional... On March 6, 2024, Aditxt, Inc (ADTX) received correspondence from 532 ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm thinks the challenges to owning United in 2025 are ...